Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UK says vaccine supply is lumpy after letter warning of significant shortfall

Wed, 17th Mar 2021 17:23

LONDON, March 17 (Reuters) - Britain’s supply of coronavirus
vaccines is “lumpy”, health minister Matt Hancock said on
Wednesday after a letter warned there would be a significant
reduction in the amount of vaccine available from March 29.

Hancock said he was confident of meeting a target to give
first vaccine doses to people in the top priority groups by the
middle of next month.

"Vaccine supply is always lumpy and we regularly send out
technical letters to the NHS to explain the ups and downs of the
supply over the future weeks, and what you're referring to is a
standard one of those letters," Hancock told a press conference.
(Reporting by Michael Holden, writing by Andrew MacAskill,
editing by William James)

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.